The DOI matches its Crossref record; 653 of the 653 references it cites were found in a registry or an index.
International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 201–400 of 653
White, E. S., Atrasz, R. G., Dickie, E. G., Aronoff, D. M., Stambolic, V., Mak, T. W., Moore, B. B., & Peters-Golden, M. L. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0126oc · Cited by 131
McGraw, D. W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25840 · Cited by 129
Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia
Liu, D., Wu, L., BREYER, R. M., Mattson, M. P., & Andreasson, K. I. (2005) · Annals of Neurology · doi:10.1002/ana.20461 · Cited by 129
Richter, M., Krauss, A. H. ‐., Woodward, D. F., & Lu¨tjen-Drecoll, E. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1281 · Cited by 128
Self-citationProstaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism
Matias, I., Chen, J., PETROCELLIS, L. D., Bisogno, T., Ligresti, A., Fezza, F., Krauss, A. H. ‐., Shi, L., Protzman, C. E., Li, C., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061705 · Cited by 128
Self-citationCOX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis
Lovgren, A. K., Jania, L. A., Hartney, J. M., Parsons, K. K., Audoly, L., FitzGerald, G. A., Tilley, S. L., & Koller, B. H. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00492.2005 · Cited by 127
EP4 Prostanoid Receptor Coupling to a Pertussis Toxin-Sensitive Inhibitory G Protein
Fujino, H., & Regan, J. W. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017749 · Cited by 127
Augmentation of allergic inflammation in prostanoid IP receptor deficient mice
Takahashi, Y., Tokuoka, S., Masuda, T., Hirano, Y., Nagao, M., Tanaka, H., Inagaki, N., Narumiya, S., & Nagai, H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704872 · Cited by 126
Self-citationAn, S., Yang, J.-H., So, S., Zeng, L., & Goetzl, E. (1994) · Biochemistry · doi:10.1021/bi00252a016 · Cited by 126
Prostaglandin E2 Mediates Cough via the EP3 Receptor: Implications for Future Disease Therapy
Maher, S. A., Birrell, M. A., & Belvisi, M. G. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0388oc · Cited by 126
Lawler, O. A., Miggin, S. M., & Kinsella, B. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104434200 · Cited by 125
Prostaglandin E receptor EP1 controls impulsive behavior under stress
Matsuoka, Y., Furuyashiki, T., Yamada, K., Nagai, T., Bito, H., Tanaka, Y. R., Kitaoka, S., Ushikubi, F., Nabeshima, T., & Narumiya, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504908102 · Cited by 124
Self-citationFiebich, B. L., Schleicher, S., Spleiss, O., Czygan, M., & Hüll, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00652.x · Cited by 122
Echeverría, V., Clerman, A., & Doré, S. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04427.x · Cited by 122
Walker, W., & Rotondo, D. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01810.x · Cited by 121
EP4 prostanoid receptor‐mediated vasodilatation of human middle cerebral arteries
Davis, R. J., Murdoch, C. E., Ali, M., Purbrick, S., Ravid, R., Baxter, G. S., Tilford, N., Sheldrick, R. L. G., Clark, K. L., & Coleman, R. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705645 · Cited by 121
Sakuma, Y., Tanaka, K., Suda, M., Yasoda, A., Natsui, K., Tanaka, I., Ushikubi, F., Narumiya, S., Segi‐Nishida, E., Sugimoto, Y., et al. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.2.218 · Cited by 121
Self-citationVelumian, A. A., Zhang, L., Pennefather, P., & Carlen, P. L. (1996) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050286 · Cited by 120
Splice Variants of the Human EP3 Receptor for Prostaglandin E2
Schmid, A., Thierauch, K., Schleuning, W.-D. D., & Dinter, H. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0023o.x · Cited by 120
Watanabe, K., Kawamori, T., Nakatsugi, S., Ohta, T., Ohuchida, S., Yamamoto, H., Maruyama, T., Kondo, K., Narumiya, S., Sügimura, T., et al. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00440-7 · Cited by 120
Self-citationGreenwood, E. (2001) · Nature reviews. Cancer · doi:10.1038/35094036 · Cited by 120
Pollock, W. K., Armstrong, R. A., Brydon, L., Jones, R. L., & MacIntyre, D. E. (1984) · Biochemical Journal · doi:10.1042/bj2190833 · Cited by 119
Self-citationProstaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation
Kay, L. J., Yeo, W. W., & Peachell, P. T. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706664 · Cited by 118
Honda, K., Arima, M., Cheng, G., Taki, S., Hirata, H., Eda, F., Fukushima, F., 山口, 文., Hatano, M., Tokuhisa, T., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022218 · Cited by 118
Li, J. H., Chou, C., Li, B., Gavrilova, O., Eisner, C. B., Schnermann, J. B., Anderson, S. A., Deng, C., Knepper, M. A., & Wess, J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39680 · Cited by 117
Yang, L., Huang, Y., Porta, R., Yanagisawa, K., González, A., Segi‐Nishida, E., Johnson, D. H., Narumiya, S., & Carbone, D. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1271 · Cited by 117
Self-citationProstaglandin E2 Inhibits Eosinophil Trafficking through E-Prostanoid 2 Receptors
Sturm, E. M., Schratl, P., Schuligoi, R., Kónya, V., Sturm, G. J., Lippe, I. T., Peskar, B. A., & Heinemann, Á. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7273 · Cited by 117
Takeuchi, K., Ukawa, H., Kato, S., Furukawa, O., Araki, H., Sugimoto, Y., ICHIKAWA, A., Ushikubi, F., & Narumiya, S. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70398-7 · Cited by 117
Self-citationCardioprotective prostacyclin signaling in vascular smooth muscle
Fetalvero, K. M., Martin, K. A., & Hwa, J. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.05.011 · Cited by 116
COX-2–Derived Prostacyclin Modulates Vascular Remodeling
Rudic, R. D., Brinster, D. R., Cheng, Y., Fries, S., Song, W., Austin, S. C., Coffman, T. M., & FitzGerald, G. A. (2005) · Circulation Research · doi:10.1161/01.res.0000170888.11669.28 · Cited by 116
Prostaglandin EP1 Receptor Contributes to Excitotoxicity and Focal Ischemic Brain Damage
Ahmad, A. S., Saleem, S., Ahmad, M., & Doré, S. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfj022 · Cited by 116
Hristovska, A.-M., Rasmussen, L. E., Hansen, P., Nielsen, S. S., Nüsing, R. M., Narumiya, S., Vanhoutte, P. M., Skøtt, O., & Jensen, B. L. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.088948 · Cited by 116
Self-citationJin, J., Shie, F., Liu, J., Wang, Y., Davis, J., Schantz, A. M., Montine, K. S., Montine, T. J., & Zhang, J. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-2 · Cited by 115
Macrophage EP4 Deficiency Increases Apoptosis and Suppresses Early Atherosclerosis
Babaev, V. R., Chew, J. D., Ding, L., Davis, S., Breyer, M. D., BREYER, R. M., Oates, J. A., Fazio, S., & Linton, M. F. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.005 · Cited by 114
Pulichino, A.-M., Rowland, S., Wu, T. Y.-H., Clark, P., Xu, D., Mathieu, M., Riendeau, D., & Audoly, L. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110387 · Cited by 114
Fujino, T., Nakagawa, N., Yuhki, K., Hara, A., Yamada, T., Takayama, K., Kuriyama, S., Hosoki, Y., Takahata, O., Taniguchi, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21382 · Cited by 114
Self-citationPrevention of Diabetic Nephropathy in Rats by Prostaglandin E Receptor EP1-Selective Antagonist
Makino, H., Tanaka, I., Mukoyama, M., Sugawara, A., Mori, K., Muro, S., Suganami, T., Yahata, K., Ishibashi, R., Ohuchida, S., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019782.37851.bf · Cited by 114
Self-citationMatsuoka, Y., Furuyashiki, T., Bito, H., Ushikubi, F., Tanaka, Y. R., Kobayashi, T., Muro, S., Satoh, N., Kayahara, T., Higashi, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0633341100 · Cited by 113
Self-citation15-Deoxy-Δ12,1412,14-prostaglandins D2 and J2 Are Potent Activators of Human Eosinophils
Monneret, G., Li, H., Vasilescu, J., Rokach, J., & Powell, W. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3563 · Cited by 113
Pan, M., Hou, M., Chang, H., & Hung, W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710038200 · Cited by 112
Nakagawa, O., Tanaka, I., Usui, T., Harada, M., Sasaki, Y., Itoh, H., Yoshimasa, T., Namba, T., Narumiya, S., & Nakao, K. (1994) · Circulation · doi:10.1161/01.cir.90.4.1643 · Cited by 112
Self-citationProstaglandin F 2α elevates blood pressure and promotes atherosclerosis
Yu, Y., Lucitt, M. B., Stubbe, J., Cheng, Y., Friis, U. G., Hansen, P., Jensen, B. L., Smyth, E. M., & FitzGerald, G. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811834106 · Cited by 112
Pierce, K. L., Fujino, H., Srinivasan, D. K., & Regan, J. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35944 · Cited by 111
Senior, J., Sangha, R., Baxter, G. S., Marshall, K. M., & Clayton, J. K. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14489.x · Cited by 110
Sturm, E. M., Sturm, G. J., Weiglhofer, I., Sandig, H., Shichijo, M., McNamee, A., Pease, J. E., Kollroser, M., Peskar, B. A., & Heinemann, Á. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310270200 · Cited by 110
Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity
Shie, F., Montine, K. S., Breyer, R. M., & Montine, T. J. (2005) · Glia · doi:10.1002/glia.20220 · Cited by 110
Martineau, L. C., McVeigh, L. I., Jasmin, B. J., & Kennedy, C. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00331.2003 · Cited by 110
Ma, H., Hara, A., Xiao, C. Y., Okada, Y., Takahata, O., Nakaya, K., Sugimoto, Y., Ichikawa, A., Narumiya, S., & Ushikubi, F. (2001) · Circulation · doi:10.1161/hc3601.094003 · Cited by 110
Self-citationThe Effects of Prostaglandin Analogues on IOP in Prostanoid FP-Receptor–Deficient Mice
Ota, T., Aihara, M., Narumiya, S., & Araie, M. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0494 · Cited by 110
Self-citationDurocher, Y., Perret, S., Thibaudeau, E., Gaumond, M.-H., Kamen, A., Stocco, R., & Abramovitz, M. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4698 · Cited by 110
Sung, Y. M., He, G., & Fischer, S. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1015 · Cited by 110
Li, M., Ke, H. Z., Qi, H., Healy, D. R., Li, Y., Crawford, D. T., Paralkar, V. M., Owen, T. A., Cameron, K. O., Lefker, B. A., et al. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.11.2033 · Cited by 109
Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting
Guan, Y., Zhang, Y., Wu, J., Qi, Z., Yang, G., Dou, D., Gao, Y., Chen, L., Zhang, X., Davis, L. S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29838 · Cited by 109
The Prostaglandin E2 Receptor EP2 Is Required for Cyclooxygenase 2–Mediated Mammary Hyperplasia
Chang, S.-H., Ai, Y., BREYER, R. M., Lane, T. F., & Hla, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0129 · Cited by 109
Thampatty, B. P., Li, H., Im, H., & Wang, J. H. (2006) · Gene · doi:10.1016/j.gene.2006.08.027 · Cited by 108
Wilson, S. J., Roche, A. M., Kostetskaia, E., & Smyth, E. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405002200 · Cited by 108
Prostaglandin D2-Induced Eosinophilic Airway Inflammation Is Mediated by CRTH2 Receptor
Shiraishi, Y., Asano, K., Nakajima, T., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078212 · Cited by 108
Nguyen, M., Solle, M., Audoly, L., Tilley, S. L., Stock, J. L., McNeish, J. D., Coffman, T. M., Dombrowicz, D., & Koller, B. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4586 · Cited by 108
Tanaka, M., Sakai, A., Uchida, S., Tanaka, S., Nagashima, M., Katayama, T., Yamaguchi, K., & Nakamura, T. (2004) · Bone · doi:10.1016/j.bone.2004.01.002 · Cited by 107
Minami, T., Nishihara, I., Uda, R., Ito, S., Hyodo, M., & Hayaishi, O. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13139.x · Cited by 107
Ishizuka, T., Kawakami, M., Hidaka, T., Matsuki, Y., Takamizawa‐Matsumoto, M., Suzuki, K., Kurita, A., & Nakamura, H. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00614.x · Cited by 107
Prostaglandin F2α Stimulates Hypertrophic Growth of Cultured Neonatal Rat Ventricular Myocytes
Adams, J. W., Migita, D. S., Yu, M. K., Young, R., Hellickson, M. S., Castro-Vargas, F. E., Domingo, J. D., Lee, P. H., Bui, J., & Henderson, S. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.1179 · Cited by 107
Spinella, F., Rosanò, L., Castro, V. D., Natali, P. G., & Bagnato, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408584200 · Cited by 106
6-isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist
Woodward, D. F., Pepperl, D. J., Burkey, T. H., & Regan, J. W. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02035-7 · Cited by 105
Self-citationClark, P., Rowland, S. E., Denis, D., Mathieu, M., Stocco, R., Poirier, H., Burch, J. D., Han, Y., Audoly, L., Therien, A. G., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134510 · Cited by 105
Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection
Ashton, A. W., Mukherjee, S., Nagajyothi, F., Huang, H., Braunstein, V. L., Desruisseaux, M. S., Factor, S. M., Lopez, L., Berman, J. W., Wittner, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062432 · Cited by 105
Richards, J. A., & Brueggemeier, R. W. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021475 · Cited by 104
Hasegawa, H., Negishi, M., & Ichikawa, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1857 · Cited by 104
Schweda, F., Klar, J., Narumiya, S., Nüsing, R. M., & Kurtz, A. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00072.2004 · Cited by 104
Self-citationSales, K. J., List, T., Boddy, S. C., Williams, A. R. W., Anderson, R. A., Naor, Z., & Jabbour, H. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0101 · Cited by 104
NILSSON, S. F. E., Drecoll, E., Lu¨tjen-Drecoll, E., Toris, C. B., Krauss, A. H. ‐., Kharlamb, A. B., Nieves, A. L., Guerra, T., & Woodward, D. F. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1627 · Cited by 103
Self-citationProstaglandin E2 receptors in bone formation
Li, M., Thompson, D. D., & Paralkar, V. M. (2007) · International Orthopaedics · doi:10.1007/s00264-007-0406-x · Cited by 103
Hara, A., Yuhki, K., Fujino, T., Yamada, T., Takayama, K., Kuriyama, S., Takahata, O., Karibe, H., Okada, Y., Xiao, C.-Y., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.527077 · Cited by 103
Self-citationTang, C., Yang, R., & Fu, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500130200 · Cited by 102
Gray, T. E., Nettesheim, P., Loftin, C. D., Koo, J.-S., Bonner, J. C., Peddada, S. D., & Langenbach, R. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.2.337 · Cited by 102
Murata, T., Lin, M. I., Aritake, K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805171105 · Cited by 102
Prostaglandin E2 Augments IL-10 Signaling and Function
Cheon, H., Rho, Y. H., Choi, S. J., Lee, Y. H., Song, G. G., Sohn, J., Won, N. H., & Ji, J. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1092 · Cited by 102
Regan, J. W., Bailey, T. J., Donello, J. E., Pierce, K. L., Pepperl, D. J., Zhang, D., Kedzie, K. M., Fairbairn, C., Bogardus, A. M., Woodward, D. F., et al. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13082.x · Cited by 101
Self-citationCharacterization of prostanoid receptor‐evoked responses in rat sensory neurones
Smith, J. A. M., Amagasu, S. M., Eglen, R. M., Hunter, J. C., & Bley, K. R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701853 · Cited by 101
Behm, D. J., Ogbonna, A. C., Wu, C. W., Burns-Kurtis, C. L., & Douglas, S. A. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145102 · Cited by 101
Cipollone, F., Fazia, M. L., Iezzi, A., Cuccurullo, C., Cesare, D. D., Ucchino, S., Spigonardo, F., Marchetti, A., Buttitta, F., Paloscia, L., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000177814.41505.41 · Cited by 101
Bley, K. R., Bhattacharya, A., Daniels, D. V., Gever, J. R., Jahangir, A. M., O-Yang, C., Smith, S., Srinivasan, D. K., Ford, A. P. D. W., & Jett, M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706554 · Cited by 99
Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors
Kabashima, K., Nagamachi, M., Honda, T., Nishigori, C., Miyachi, Y., TOKURA, Y., & Narumiya, S. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700491 · Cited by 99
Self-citationThromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis
Dogné, J., Hanson, J., & Praticò, D. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.001 · Cited by 99
Targeting Prostaglandin E2 EP1 Receptors Prevents Seizure-Associated P-glycoprotein Up-Regulation
Pekcec, A., Unkrüer, B., Schlichtiger, J., Soerensen, J., Hartz, A. M. S., Bauer, B., van Vliet, E. A., Gorter, J. A., & Potschka, H. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.152520 · Cited by 99
Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1
Nagamachi, M., Sakata, D., Kabashima, K., Furuyashiki, T., Murata, T., Segi‐Nishida, E., Soontrapa, K., Matsuoka, T., Miyachi, Y., & Narumiya, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070773 · Cited by 99
Self-citationIdentification of specific EP receptors responsible for the hemodynamic effects of PGE2
Audoly, L., Tilley, S. L., Goulet, J. L., et al. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.3.h924 · Cited by 99
Kunikata, T., Tanaka, A., Miyazawa, T., Kato, S., & Takeuchi, K. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1014725024519 · Cited by 98
McIlroy, A., Caron, G., Blanchard, S., Frémaux, I., Duluc, D., Delneste, Y., Chevailler, A., & Jeannin, P. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02326.x · Cited by 98
Takadera, T. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.02.005 · Cited by 98
Potent contractile actions of prostanoid EP3‐receptor agonists on human isolated pulmonary artery
Qian, Y., Jones, R. L., Chan, K., Stock, A. I., & Ho, J. K. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb16997.x · Cited by 96
Self-citationCardiovascular hazard and non-steroidal anti-inflammatory drugs
Wong, D., Wang, M., Cheng, Y., & FitzGerald, G. A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.02.001 · Cited by 95
Okano, M., Sugata, Y., Fujiwara, T., Matsumoto, R., Nishibori, M., Shimizu, K., Maeda, M., Kimura, Y., Kariya, S., Hattori, H., et al. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02376.x · Cited by 95
Armstrong, R. A. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00103-9 · Cited by 95
Activation of the D Prostanoid Receptor 1 Regulates Immune and Skin Allergic Responses
Angeli, V., Staumont-Sallé, D., Charbonnier, A.-S., Hammad, H., Gosset, P., Pichavant, M., Lambrecht, B. N., Capron, M., Dombrowicz, D., & Trottein, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3822 · Cited by 94
Li, X., Pilbeam, C. C., Pan, L. C., BREYER, R. M., & Raisz, L. G. (2002) · Bone · doi:10.1016/s8756-3282(02)00683-x · Cited by 94
Kassuya, C. A. L., Ferreira, J., Claudino, R. F., & Calixto, J. Β. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707149 · Cited by 94
Positioning prostanoids of the D and J series in the immunopathogenic scheme
Herlong, J. L., & Scott, T. R. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.10.004 · Cited by 94
Different responsiveness of prostaglandin D2‐sensitive systems to prostaglandin D2 and its analogues
Narumiya, S., & Toda, N. (1985) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1985.tb08870.x · Cited by 94
Self-citationUeno, A., Naraba, H., Ikeda‐Matsuo, Y., Ushikubi, F., Murata, T., Narumiya, S., & Oh‐ishi, S. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00420-3 · Cited by 94
Self-citationSales, K. J., Milne, S. A., Williams, A. R. W., Anderson, R. A., & Jabbour, H. N. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031434 · Cited by 94
Alternative splicing generates multiple isoforms of a rabbit prostaglandin E2 receptor.
BREYER, R. M., Emeson, R. B., Jl, T., Breyer, M. D., Davis, L. S., Abromson, R. M., & Ferrenbach, S. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37583-x · Cited by 93
Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost.
Weinreb, R. N., & Lindsey, J. D. (2002) · PubMed · Cited by 93
Chen, Q., Muramoto, K., Masaaki, N., Ding, Y., Yang, H., Mackey, M., Li, W., Inoue, Y., Ackermann, K. E., Shirota, H., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00647.x · Cited by 93
Liang, Y., Woodward, D. F., Guzman, V. M., Li, C., Scott, D. F., Wang, J. W., Wheeler, L. A., Garst, M. E., Landsverk, K., Sachs, G. M., et al. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.142 · Cited by 93
Self-citationTalpain, E., Armstrong, R. A., Coleman, R. A., & Vardey, C. J. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13370.x · Cited by 93
Leone, V., di Palma, A., Ricchi, P., Acquaviva, F., Giannouli, M., Prisco, A. M. D., Iuliano, F., & Acquaviva, A. M. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00584.2006 · Cited by 93
Colon Cancer — Understanding How NSAIDs Work
Clevers, H. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmcibr055457 · Cited by 93
Prostanoids as pharmacological targets in COPD and asthma
Rolin, S., Masereel, B., & Dogné, J.-M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.058 · Cited by 92
Bimatoprost, Prostamide Activity, and Conventional Drainage
Wan, Z., Woodward, D. F., Cornell, C. L., Fliri, H. G., Martos, J. L., Pettit, S. N., Wang, J. W., Kharlamb, A. B., Wheeler, L. A., Garst, M. E., et al. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0080 · Cited by 92
Self-citationUrinary concentrating function in mice lacking EP3receptors for prostaglandin E2
Fleming, E. F., Athirakul, K., Oliverio, M. I., Key, M. L., Goulet, J. L., Koller, B. H., & Coffman, T. M. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.275.6.f955 · Cited by 92
Sanner, J. H. (1969) · PubMed · Cited by 92
Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells
Zhou, W., Blackwell, T. S., Goleniewska, K., et al. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0606375 · Cited by 91
Woodward, D. F., Carling, R. W., Cornell, C. L., Fliri, H. G., Martos, J. L., Pettit, S. N., Liang, Y., & Wang, J. W. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.001 · Cited by 91
Self-citationOh, D.-J., Martin, J. L., Williams, A. J., Russell, P., Birk, D. E., & Rhee, D. J. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0036 · Cited by 91
EP2 receptor mediates bronchodilation by PGE2 in mice
Sheller, J. R., Mitchell, D. B., Meyrick, B. O., et al. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.6.2214 · Cited by 91
Ali, F. Y., Egan, K. M., FitzGerald, G. A., Desvergne, B., Wahli, W., Bishop‐Bailey, D., Warner, T. D., & Mitchell, J. A. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0289oc · Cited by 90
Nakamura, Y., Nakamura, K., & Morrison, S. F. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.041 · Cited by 90
Generation of a conditional allele of the mouse prostaglandin EP4 receptor
Schneider, A., Guan, Y., Zhang, Y., Magnuson, M. A., Pettepher, C., Loftin, C. D., Langenbach, R. I., BREYER, R. M., & Breyer, M. D. (2004) · genesis · doi:10.1002/gene.20048 · Cited by 90
Prostaglandin D2Protects Neonatal Mouse Brain from Hypoxic Ischemic Injury
Taniguchi, H., Mohri, I., Okabe-Arahori, H., Aritake, K., Wada, K., Kanekiyo, T., Narumiya, S., Nakayama, M., Ozono, K., Urade, Y., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0321-07.2007 · Cited by 89
Self-citationFrancesco, L. D., Totani, L., Dovizio, M., Piccoli, A. L., Jr., Francesco, A. D., Salvatore, T., Pandolfi, A., Evangelista, V., Dercho, R. A., Seta, F., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.191114 · Cited by 89
Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice
Li, M., Healy, D. R., Li, Y., Simmons, H. A., Crawford, D. T., Ke, H. Z., Pan, L. C., Brown, T. A., & Thompson, D. D. (2005) · Bone · doi:10.1016/j.bone.2005.03.016 · Cited by 88
Prostanoids and inflammation: a new concept arising from receptor knockout mice
Narumiya, S. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0500-1 · Cited by 88
Self-citationBone biomechanical properties in prostaglandin EP1 and EP2 knockout mice
Akhter, M. P., Cullen, D. M., Gong, G., & Recker, R. R. (2001) · Bone · doi:10.1016/s8756-3282(01)00486-0 · Cited by 88
Jiang, G.-L., Nieves, A. L., Im, W. B., Old, D. W., Dinh, D. D., & Wheeler, L. A. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111146 · Cited by 88
Prostacyclin signaling in the kidney: implications for health and disease
Nasrallah, R., & Hébert, R. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00454.2004 · Cited by 88
Chen, B.-C., Liao, C.-C., Hsu, M., Liao, Y., Lin, C., Sheu, J., & Lin, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.681 · Cited by 87
Prostaglandin EP4 receptor agonist protects against acute neurotoxicity
Ahmad, A. S., Ahmad, M., de Brum-Fernandes, A. J., & Doré, S. (2005) · Brain Research · doi:10.1016/j.brainres.2005.10.068 · Cited by 87
AH6809, a prostaglandin DP‐receptor blocking drug on human platelets
Keery, R. J., & Lumley, P. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11584.x · Cited by 87
Méndez, M., & LaPointe, M. C. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00838.2004 · Cited by 87
Studies on the ocular pharmacology of prostaglandin D2.
Woodward, D. F., HAWLEY, S. B., Williams, L. S., et al. (1990) · PubMed · Cited by 86
Self-citationMilne, S. A., & Jabbour, H. N. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021368 · Cited by 86
Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors
Armstrong, R. A., Lawrence, R. A., Jones, R. L., Wilson, N. H., & Collier, A. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb12001.x · Cited by 86
Self-citationKim, H.-J., Chung, J.-I., Lee, S., Jung, Y., Moon, C., & Baik, E. J. (2008) · Brain Research · doi:10.1016/j.brainres.2007.12.017 · Cited by 86
Yoshida-Court, K., Nakamura, K., Matsumura, K., Kanosue, K., König, M., Thiel, H., Boldogkői, Z., Tóth, I. E., Roth, J., Gerstberger, R., et al. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02919.x · Cited by 86
Prostaglandin E2 Strongly Inhibits Human Osteoclast Formation
Take, I., Kobayashi, Y., Yamamoto, Y., Tsuboi, H., Ochi, T., Uematsu, S., Okafuji, N., Kurihara, S., Udagawa, N., & Takahashi, N. (2005) · Endocrinology · doi:10.1210/en.2005-0451 · Cited by 85
Lawrence, R. A., & Jones, R. L. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09063.x · Cited by 85
Self-citationLim, H. J., & Dey, S. K. (1997) · Endocrinology · doi:10.1210/endo.138.11.5528 · Cited by 85
Chevalier, É., Stock, J., Fisher, T., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2056 · Cited by 84
Yoshimura-Uchiyama, C., Iikura, M., Yamaguchi, M., Nagase, H., Ishii, A. I., Matsushima, K., Yamamoto, K., Shichijo, M., Bacon, K. B., & Hirai, K. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.02027.x · Cited by 84
Abé, H., Takeshita, T., Nagata, K., Arita, T., Endo, Y., Fujita, T., Takayama, H., Kubo, M., & Sugamura, K. (1999) · Gene · doi:10.1016/s0378-1119(98)00599-x · Cited by 84
Prostaglandin F2 alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo
Lai, J., Jin, H., Yang, R., Winer, J., Li, W., Yen, R., King, K. L., Zeigler, F., Ko, A., Cheng, J., et al. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.271.6.h2197 · Cited by 83
Importance of the EP1 Receptor in Cutaneous UVB-Induced Inflammation and Tumor Development
Tober, K. L., Wilgus, T. A., Kusewitt, D. F., Thomas‐Ahner, J. M., Maruyama, T., & Oberyszyn, T. M. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700014 · Cited by 83
Discovery of a potent and selective agonist of the prostaglandin EP4 receptor
Billot, X., Châteauneuf, A., Chauret, N., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00042-8 · Cited by 83
Chen, D.-B., Westfall, S. D., Fong, H. W., Roberson, M. S., & Davis, J. S. (1998) · Endocrinology · doi:10.1210/endo.139.9.6197 · Cited by 82
Discovery of Three Novel Orphan G-Protein-Coupled Receptors
Marchese, A., Sawzdargo, M., Nguyen, T., Cheng, R., Heng, H. H., Nowak, T., Im, D., Lynch, K. R., George, S. R., & O’Dowd, B. F. (1999) · Genomics · doi:10.1006/geno.1998.5655 · Cited by 82
FRIAS, M., Rebsamen, M. C., Gerber-Wicht, C., & Lang, U. E. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.09.016 · Cited by 82
Hawcroft, G., Ko, C. W. S., & Hull, M. A. (2006) · Oncogene · doi:10.1038/sj.onc.1210113 · Cited by 81
McKenniff, M. G., Rodger, I. W., Norman, P., et al. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90601-2 · Cited by 81
Effects of PGF2α on human melanocytes and regulation of the FP receptor by ultraviolet radiation
SCOTT, G. A., Jacobs, S. E., Leopardi, S., Anthony, F. A., Learn, D., Malaviya, R., & Pentland, A. P. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.11.016 · Cited by 81
Vasorelaxation induced by prostaglandin E2in human pulmonary vein: role of the EP4receptor subtype
Foudi, N., Kotelevets, L., Louedec, L., Lesèche, G., Hénin, D., Chastre, E., & Norel, X. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.214 · Cited by 80
Shiraishi, Y., Asano, K., Niimi, K., Fukunaga, K., Wakaki, M., Kagyo, J., Takihara, T., Ueda, S., Nakajima, T., Oguma, T., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.541 · Cited by 78
TAKEUCHI, K., Kato, S., ARAKI, H., Komoike, Y., & TAKEEDA, M. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)80669-7 · Cited by 78
Town, H.-H., CASALS‐STENZEL, J., & Schillinger, E. (1983) · Prostaglandins · doi:10.1016/0090-6980(83)90131-4 · Cited by 78
Nitta, M., Hirata, I., Toshina, K., et al. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2002.01096.x · Cited by 78
PGE2 Signaling Through the EP4 Receptor on Fibroblasts Upregulates RANKL and Stimulates Osteolysis
Tsutsumi, R., Xie, C. L., Wei, X., Zhang, M., Zhang, X., Flick, L. M., Schwarz, E. M., & O’Keefe, R. J. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090412 · Cited by 78
Expression and Molecular Pharmacology of the Mouse CRTH2 Receptor
Hata, A. N., Zent, R., Breyer, M. D., & BREYER, R. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.050955 · Cited by 77
Cloning of human prostanoid receptors
Pierce, K. L., Gil, D. W., Woodward, D. F., & Regan, J. W. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89035-5 · Cited by 77
Self-citationInvolvement of Prostaglandin E2 in Production of Amyloid-β Peptides Both in Vitro and in Vivo
Hoshino, T., Nakaya, T., Homan, T., Tanaka, K., Sugimoto, Y., Araki, W., Narita, M., Narumiya, S., Suzuki, T., & Mizushima, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703087200 · Cited by 76
Self-citationWright, D. H., Metters, K. M., Abramovitz, M., & Ford‐Hutchinson, A. W. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701708 · Cited by 76
Stubbs, V. E. L., Schratl, P., Hartnell, A., Williams, T. J., Peskar, B. A., Heinemann, Á., & Sabroe, I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201803200 · Cited by 76
Liang, Y., Li, C., Guzman, V. M., Evinger, A. J., Protzman, C. E., Krauss, A. H.-P., & Woodward, D. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301009200 · Cited by 75
Self-citationMiyamoto, M. R., Ito, H., Mukai, S., Kobayashi, T., Yamamoto, H., Kobayashi, M., Maruyama, T., Akiyama, H., & Nakamura, T. (2003) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(03)00118-3 · Cited by 75
Bradbury, D. A., Newton, R. C., Zhu, Y. M., El-Haroun, H., Corbett, L. M., & Knox, A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307964200 · Cited by 75
EP2receptors mediate airway relaxation to substance P, ATP, and PGE2
Fortner, C. N., BREYER, R. M., & Paul, R. J. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.2.l469 · Cited by 75
Jaffar, Z. H., Ferrini, M. E., Buford, M. C., FitzGerald, G. A., & Roberts, K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6193 · Cited by 74
Major roles of prostanoid receptors IP and EP3 in endotoxin-induced enhancement of pain perception
Ueno, A., Matsumoto, H., Naraba, H., Ikeda‐Matsuo, Y., Ushikubi, F., Matsuoka, T., Narumiya, S., Sugimoto, Y., Ichikawa, A., & Oh‐ishi, S. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00654-2 · Cited by 74
Self-citationSingh, J., Zeller, W. E., Zhou, N., Hategen, G., Mishra, R. K., Polozov, A., Yu, P., Onua, E., Zhang, J., Zembower, D. E., et al. (2009) · ACS Chemical Biology · doi:10.1021/cb8002094 · Cited by 74
Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents
Brueggemeier, R. W., Richards, J. A., Joomprabutra, S., Bhat, A., & Whetstone, J. L. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00127-3 · Cited by 74
Thromboxane A2 stimulated signal transduction in vascular smooth muscle.
Dorn, G. W., & Becker, M. W. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38141-3 · Cited by 74
The Role of the Prostaglandin D2 Receptor, DP, in Eosinophil Trafficking
Schratl, P., Royer, J. F., Kostenis, E., Ulven, T., Sturm, E. M., Waldhoer, M., Höefler, G., Schuligoi, R., Lippe, I. T., Peskar, B. A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4792 · Cited by 73
Jenkins, D. W., Feniuk, W., & Humphrey, P. P. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704357 · Cited by 73
The Role of PGE 2 Receptor EP 4 in Pathologic Ocular Angiogenesis
Yanni, S. E., Barnett, J. M., Clark, M. L., & Penn, J. S. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3652 · Cited by 73
Prostaglandin E Receptor EP3 Subtype Induces Neurite Retraction via Small GTPase Rho
Katoh, H., Negishi, M., & Ichikawa, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29780 · Cited by 72
Krause, P., Singer, E., Darley, P. I., Klebensberger, J., Groettrup, M., & Legler, D. F. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0905519 · Cited by 72
Amano, H., Ito, Y., Suzuki, T., Kato, S., Matsui, Y., Ogawa, F., Murata, T., Sugimoto, Y., Senior, R. M., Kitasato, H., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01322.x · Cited by 71
Self-citationProstaglandin F2α stimulates motility and invasion in colorectal tumor cells
Qualtrough, D., Kaidi, A., Chell, S. D., Jabbour, H. N., Williams, A. C., & Paraskeva, C. (2007) · International Journal of Cancer · doi:10.1002/ijc.22755 · Cited by 71
Li, R.-C., Cindrová‐Davies, T., Skepper, J. N., & Sellers, L. A. (2004) · Circulation Research · doi:10.1161/01.res.0000121568.40692.97 · Cited by 71
Chun, K., Lao, H.-C., Trempus, C. S., Okada, M., & Langenbach, R. I. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp168 · Cited by 71
Gallant, M. A., Samadfam, R., Hackett, J. A., Antoniou, J., Parent, J.-L., & de Brum-Fernandes, A. J. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041211 · Cited by 70
Altered hippocampal long‐term synaptic plasticity in mice deficient in the PGE2 EP2 receptor
Yang, H., Zhang, J., BREYER, R. M., & Chen, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05766.x · Cited by 70
Prostanoid receptors in anagen human hair follicles
Colombe, L., Michelet, J., & Bernard, B. A. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00639.x · Cited by 70
Monneret, G., Cossette, C., Gravel, S., Rokach, J., & Powell, W. S. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042937 · Cited by 70
Stimulation of Prostaglandin EP2 Receptors Prevents NMDA-Induced Excitotoxicity
Ahmad, A. S., Zhuang, H., Echeverrı́a, V., et al. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.1895 · Cited by 70
Serrero, G., & Lepak, N. M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6433 · Cited by 69
Proneoplastic effects of PGE2mediated by EP4 receptor in colorectal cancer
Doherty, G. A., Byrne, S. M., Molloy, E. S., Malhotra, V., Austin, S. C., Kay, E. W., Murray, F. E., & Fitzgerald, D. J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-207 · Cited by 69
Hallinan, E. A., Stapelfeld, A., Savage, M. A., & Reichman, M. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(94)80027-8 · Cited by 69
Wang, X. S., & Lau, H. Y. A. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01043.x · Cited by 69
Boku, K., Ohno, T., Saeki, T., Hayashi, H., Hayashi, I., Katori, M., Murata, T., Narumiya, S., Saigenji, K., & Majima, M. (2001) · Gastroenterology · doi:10.1053/gast.2001.20916 · Cited by 67
Self-citationSavonenko, A. V., Muñoz, P., Melnikova, T., Wang, Q., Liang, X., BREYER, R. M., Montine, T. J., Kirkwood, A., & Andreasson, K. I. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.016 · Cited by 67
Oka, T., Aou, S., & Hori, T. (1994) · Brain Research · doi:10.1016/0006-8993(94)91275-0 · Cited by 67
Hoshino, T., Namba, T., Takehara, M., Nakaya, T., Sugimoto, Y., Araki, W., Narumiya, S., Suzuki, T., & Mizushima, T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003269 · Cited by 67
Self-citationNicola, C., Timoshenko, A. V., Dixon, S. J., Lala, P. K., & Chakraborty, C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0413 · Cited by 66
Mori, A., Saito, M., Sakamoto, K., Narita, M., Nakahara, T., & Ishii, K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.052 · Cited by 65
Ji, R., Chou, C.-L., Xu, W., Chen, X.-B., Woodward, D. F., & Regan, J. W. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.063933 · Cited by 65
Self-citationProstanoids in immunity: Roles revealed by mice deficient in their receptors
Narumiya, S. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.09.025 · Cited by 64
Self-citationKe, H. Z., Crawford, D. T., Qi, H., Simmons, H. A., Owen, T. A., Paralkar, V. M., Li, M., Lu, B., GRASSER, W. A., Cameron, K. O., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051110 · Cited by 64
Prostaglandin E receptor subtype EP1 deficiency inhibits colon cancer development
Kawamori, T. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh322 · Cited by 64
Gosset, P., Pichavant, M., Faveeuw, C., Bureau, F., Tonnel, A., & Trottein, F. (2005) · European Journal of Immunology · doi:10.1002/eji.200425319 · Cited by 63
Ono, K., Kaneko, H., Choudhary, S., Pilbeam, C. C., Lorenzo, J., Akatsu, T., Kugai, N., & Raisz, L. G. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041027 · Cited by 63
Cited by
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Sitbon, O., Channick, R., Chin, K. M., Frey, A., Gaine, S., Galiè, N., Ghofrani, H.-A., Hoeper, M. M., Lang, I. M., Preiss, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503184 · Cited by 1,060
General Pathways of Pain Sensation and the Major Neurotransmitters Involved in Pain Regulation
Yam, M. F., Loh, Y. C., Tan, C. S., Khadijah Adam, S., Abdul Manan, N., & Basir, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082164 · Cited by 652
Illuminating G-Protein-Coupling Selectivity of GPCRs
Inoue, A., Raimondi, F., Kadji, F. M. N., Singh, G., Kishi, T., Uwamizu, A., Ono, Y., Shinjo, Y., Ishida, S., Arang, N., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.044 · Cited by 638
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Enzymes of the Cyclooxygenase Pathways of Prostanoid Biosynthesis
Smith, W. L., Urade, Y., & Jakobsson, P.-J. (2011) · Chemical Reviews · doi:10.1021/cr2002992 · Cited by 503
Metadata
- Authors
- Woodward, D. F., Jones, R. L., & Narumiya, S.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 63
- Issue
- 3
- Pages
- 471-538
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2111015948
- Cited by
- 443
- References
- 653
- FWCI
- 25.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.